- Social:
AstraZeneca
Vice President and Head of Infection for Global Medicines Development at the pharmaceutical company AstraZeneca
PROFILE
John Rex
Guest
FROM John Rex
To the Point
Bugs, Drugs and Super-bugs Public health officials don't want to "cry wolf" or frighten people more than needed. So, they don't often use apocalyptic language. That's why it's rare to hear the head of the US Centers for Disease Control and Prevention warn about an impending "nightmare" or his British counterpart talk about a threat comparable to "terrorism ." But that's how they are describing the growing resistance of bacteria to antibiotics, which could set medicine back by a hundred years. Over-prescription by doctors and use in farm animals get part of the blame, and despite the need for new antibiotics, Big Pharma is cutting back on research and development. It's an all-too familiar problem that's becoming increasingly urgent. What will it take to solve it? What can we do in the meantime?
Recommended
LRC Presents: All the President's Lawyers
[ ██████████ ] Mueller’s sentencing memo for Michael Flynn might have redacted “all the sexy parts,” but Josh Barro and Ken White speculate on the black bars.
KCRW Features
One Year Later: City of Ventura Faced the Thomas Fire When the Thomas Fire hit the city limits, residents fled for their lives. They recall midnight evacuations and near misses.
Red State, Blue State
Americans are Sick and Tired of Politics America feels more divided than ever. But the majority of the electorate is actually united on something: they are tuning out from political debates.
To the Point
Trump Sees ‘Bipartisanship’ on Criminal Justice Reform After decades, America’s draconian crackdown on crime isn’t working. Even most conservatives agree with liberals that it’s worse than a waste of money. President Trump has used a rare word when it comes to proposed reform: “bipartisanship.” It could happen before the new Congress takes office--but Senate Majority Leader Mitch McConnell might be applying the brakes.